ロード中...
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial
BACKGROUND: Allergen-specific immunotherapy represents the only disease-modifying treatment for allergic diseases. We and others have previously demonstrated that intralymphatic immunotherapy (ILIT), a less time-consuming alternative to conventional subcutaneous immunotherapy (SCIT), is safe and eff...
保存先:
| 出版年: | Respir Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4728811/ https://ncbi.nlm.nih.gov/pubmed/26817454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0324-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|